Core Viewpoint - The article highlights the performance of the top-performing stocks in May, emphasizing the significant gains in various sectors, particularly in logistics, innovative pharmaceuticals, and controlled nuclear fusion concepts [3][4]. Group 1: Stock Performance - As of May 30, the Shanghai Composite Index increased by 2.09%, the Shenzhen Component Index rose by 1.42%, and the ChiNext Index gained 2.32% during the month [3]. - Among the top ten stocks, 中邮科技 (China Post Technology) had the highest increase of 157.28%, followed by 舒泰神 (Shutai Shen) with 145.37%, and 王子新材 (Wangzi New Materials) with 108.37% [4][5][6]. Group 2: Company Highlights - 中邮科技 (China Post Technology) focuses on smart logistics systems, with a market capitalization of 9.1 billion yuan as of May 30. The stock price surged from 26 yuan to 67 yuan during May [5]. - 舒泰神 (Shutai Shen) specializes in innovative biopharmaceuticals, with core products including the national class I new drug "苏肽生" and a constipation treatment "舒泰清" [7]. - 王子新材 (Wangzi New Materials) is involved in controlled nuclear fusion, with its stock experiencing significant volatility. The company clarified that its involvement in fusion projects is limited and does not significantly impact its revenue [8]. - 合锻智能 (HeDuan Intelligent) also operates in the controlled nuclear fusion sector, reporting over 200 million yuan in orders for core components of Tokamak devices [9]. - 路桥信息 (LuQiao Information) focuses on traffic information solutions and saw a stock increase of 102.64% during May [10]. - 成飞集成 (Chengfei Integration) reported a 99.52% increase in stock price, with its main business in automotive parts and tools [11]. - 三生国健 (SanSheng GuoJian) announced a collaboration with Pfizer for a dual-specific antibody, with a record upfront payment of 1.25 billion USD for the licensing agreement [12][13]. - *ST亚振 (ST Yazhen) experienced a 93.14% increase, attributed to a change in controlling shareholder, which is expected to enhance the company's operational support [14]. - 中洲特材 (Zhongzhou Special Materials) is involved in high-temperature corrosion-resistant alloys but clarified that its products are not yet applied in controlled nuclear fusion [15]. - 七丰精工 (Qifeng Precision) aims for a 10.02% revenue growth in 2024, focusing on aerospace and rail transportation sectors [16].

Group 1 - The secondary market for "unmanned vehicles" is experiencing significant activity, with multiple concept stocks surging, including Zhongyou Technology, which saw its stock price deviate by over 100% in the 10 trading days from May 16 to May 29, 2025, and over 200% in the 22 trading days from April 25 to May 29, 2025 [1][2] - As of May 29, 2025, Zhongyou Technology's stock closed at 68.48 yuan per share, with a latest price-to-book ratio of 6.06, significantly higher than the industry average of 2.76 [2] - The company's main business includes intelligent sorting systems and intelligent transmission systems, which are leading in efficiency and accuracy for automated sorting of various items [3] Group 2 - In the 2024 annual report, Zhongyou Technology reported a revenue of 912 million yuan, a year-on-year decline of 53.26%, and a net profit attributable to shareholders of -148 million yuan, a decline of 306.52% [4] - The fourth quarter of 2024 showed total revenue of 318 million yuan, down 59.16% year-on-year but up 53.62% quarter-on-quarter, with a net profit of -78.84 million yuan, a year-on-year decline of 255.10% [4]

科创板投资风险提示：本次发行股票拟在科创板上市，科创板公司具有研发投入大、经营风险高、 业绩不稳定、退市风险高等特点，投资者面临较大的市场风险。投资者应充分了解科创板的投资 风险及本公司所披露的风险因素，审慎作出投资决定。 中邮科技股份有限公司 China Post Technology Co., Ltd. （住所：上海市普陀区中山北路 3185 号） 首次公开发行股票并在科创板上市 招股意向书 联席保荐机构（主承销商） 住所：陕西省西安市唐延路 5 号 （陕西邮政信息大厦 9-11 层） 中邮科技股份有限公司 招股意向书 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对注册申请文 件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或保证。任何与之相反的声明均属虚假不 实陈述。 根据《证券法》的规定，股票依法发行后，发行人经营与收益的变化，由发行人自 行负责；投资者自主判断发行人的投资价值，自主作出投资决策，自行承担股票依法发 行后因发行人经营与收益变化或者股票价格变动引致的投资风险。 1-1-1 中邮科技股份有限公司 ...

中邮科技股份有限公司 首次公开发行股票并在科创板上市 招股意向书附录 | 序号 | 名称 | 页码 | | --- | --- | --- | | 1 | 发行保荐书 | 1 | | 2 | 财务报告及审计报告 | 62 | | 3 | 内部控制鉴证报告 | 238 | | 4 | 经注册会计师鉴证的非经常性损益明细表 | 252 | | 5 | 法律意见书 | 266 | | 6 | 律师工作报告 | 439 | | 7 | 发行人公司章程（草案） | 650 | | 8 | 关于同意中邮科技股份有限公司首次公开发行股票注册的批复 | 702 | 中国国际金融股份有限公司 关于 中邮科技股份有限公司 首次公开发行股票并在科创板上市的 发行保荐书 联席保荐机构 （主承销商） （北京市朝阳区建国门外大街 1 号国贸大厦 2 座 27 层及 28 层） 1 中邮科技股份有限公司 发行保荐书 关于中邮科技股份有限公司 首次公开发行股票并在科创板上市的发行保荐书 中国证券监督管理委员会、上海证券交易所： 中邮科技股份有限公司（以下简称"中邮科技"、"发行人"或"公司"）拟申请首 次公开发行股票并在科创板上市（以下简称 ...

科创板投资风险提示：本次发行股票拟在科创板上市，科创板公司具有研发投入大、经营风险高、 业绩不稳定、退市风险高等特点，投资者面临较大的市场风险。投资者应充分了解科创板的投资 风险及本公司所披露的风险因素，审慎作出投资决定。 中邮科技股份有限公司 China Post Technology Co., Ltd. （住所：上海市普陀区中山北路 3185 号） 首次公开发行股票并在科创板上市 招股说明书 （注册稿） 本公司的发行申请尚需经上海证券交易所和中国证监会履行相应程序。本招股说明书不具有据以 发行股票的法律效力，仅供预先披露之用。投资者应当以正式公告的招股说明书作为作出投资决 定的依据。 联席保荐机构（主承销商） 住所：北京市朝阳区建国门外大街 1 号 国贸大厦 2 座 27 层及 28 层 住所：陕西省西安市唐延路 5 号 （陕西邮政信息大厦 9-11 层） 中邮科技股份有限公司 招股说明书（注册稿） 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对注册申请文 件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的盈利能力、 投资价值或者对投资者的收益作出实质性判断或保证。 ...